Energy & metabolism
MOTS-c
MOTS-c, a mitochondrial-derived research peptide studied for metabolism, energy and endurance. Clean, third-party tested.

Body Pharm MOTS-C 32 Pen
R2 200.00
The Body Pharm MOTS-C 10 Vial is the clearest current South African MOTS-c offer with stated batch documentation and cold-chain fulfilment.
| Product | Brand | Format | Price (ZAR) | Availability |
|---|---|---|---|---|
| MOTS-C 10 Vial | Body Pharm | 10 mg vial | See live product page | InStock |
The South African MOTS-c market in 2026 remains research-stage rather than an established therapeutic option. The MOTS-MET Phase 2 trial (NCT07505745), registered February 2026, recruits adults with prediabetes and overweight/obesity to measure insulin sensitivity via oral glucose tolerance testing, with completion expected no earlier than late 2026 [1][2]. No peer-reviewed human efficacy data for fat loss or metabolic outcomes was available as of 2026 [1][2][3].
Key Takeaways
- A 10 mg vial from Body Pharm comes with batch-specific CoA and cold-chain fulfilment, the clearest documented offer in South Africa
- MOTS-c is investigational only: no completed human efficacy data and no established therapeutic use as of 2026
- The MOTS-MET Phase 2 trial (NCT07505745) is recruiting since February 2026; primary endpoint is insulin sensitivity, not fat loss
- A Certificate of Analysis proves purity and identity testing only, never clinical efficacy or human safety
- Compare with established alternatives: semaglutide for weight loss or NAD+ for energy support
Shop Body Pharm MOTS-C 10 Vial
MOTS-c at a glance: price, format and proof
BeSkinny's clearest documented MOTS-c offer is the Body Pharm MOTS-C 10 Vial, available now with batch-specific testing documentation and cold-chain fulfilment.
| Product | Brand | Format | Price | Availability |
|---|---|---|---|---|
| MOTS-C 10 Vial | Body Pharm | 10 mg vial | See live product page | InStock |
SKU: bpmots10 | Purchase: beskinny.store/shop/body-pharm-mots-c-10
What we can verify about this listing
Every batch is third-party tested for purity and identity, with a Certificate of Analysis available on the product page or by email request before purchase. Products are handled cold-chain from storage through dispatch. We ship within South Africa only; orders placed and paid before 12:00 on a business day typically ship same-day via The Courier Guy or Aramex, with next-day delivery to major metros and 2-5 working days to outlying areas [6][12].
What remains unverified
Merchant descriptions of MOTS-c benefits, including fat loss, improved insulin sensitivity or greater endurance, are not independent evidence that this batch produces those outcomes. The MOTS-MET Phase 2 trial (NCT07505745) registered February 2026 is still recruiting; no peer-reviewed human efficacy data for metabolic or weight outcomes was available as of 2026 [1][2].
Shop Body Pharm MOTS-C 10 Vial
For readers comparing MOTS-c with other wellness compounds, see BeSkinny's wellness and recovery peptides. Those evaluating established weight-loss injectables rather than research-phase peptides should see BeSkinny's semaglutide buyer's guide.
MOTS-c peptide benefits: what is established?
A MOTS-c Certificate of Analysis proves reported batch identity and purity testing, not that the peptide produces any metabolic, energy or endurance benefit in humans [11][12].
| What sellers claim | What research actually tests | What a CoA can show |
|---|---|---|
| Energy and metabolism support | Mitochondrial-derived peptide mechanism in cellular models; human trials pending | Peptide identity by analytical method |
| Endurance and fat metabolism | Not a primary endpoint in any registered 2024-2026 human trial [1][2] | Purity percentage for the specific batch |
| Insulin sensitivity improvement | Primary endpoint in MOTS-MET Phase 2 trial (recruiting since February 2026) [1][2] | Testing laboratory and date |
| Longevity and glucose regulation | Secondary endpoints (HbA1c, fasting glucose) in same trial; no completed efficacy data [1][2] | Batch or lot number traceability |
The strongest current human evidence is the MOTS-MET study (NCT07505745), registered February 2026, which measures oral-glucose-tolerance-test-derived insulin sensitivity as its primary endpoint in adults with prediabetes and overweight/obesity [1][2]. Secondary endpoints include HbA1c, body weight and safety measures, but no results are available as of 2026 [1][2].
Claims from commercial summaries about 2024 Phase 1 clamp studies or 2025 prediabetes trials lack verifiable peer-reviewed citations and should be treated as unverified [3][4][5]. MOTS-c remains an investigational compound, not an established metabolic or weight-loss therapy [13].
Evaluating claims about fat loss and insulin sensitivity
Is MOTS-c useful for fat loss?
No. MOTS-c is not a proven fat-loss treatment in humans as of 2026. The strongest current human evidence, the MOTS-MET Phase 2 trial registered February 2026, measures insulin sensitivity and glucose endpoints, not body-fat reduction, as its primary outcome [1][2]. No completed, peer-reviewed trial has demonstrated meaningful fat loss in people using MOTS-c [1][2][3].
A merchant description stating that MOTS-c "supports fat metabolism" or "aids weight management" is not independent evidence that a particular batch produces fat loss. Such language typically references cellular or animal studies on mitochondrial function, not clinical outcomes in humans [3][4]. Treat any fat-loss claim without a specific peer-reviewed citation showing body-composition results as unverified [3].
| What sellers may claim | What the evidence actually shows |
|---|---|
| "Supports fat metabolism" | Mitochondrial energy pathways studied in cellular and animal models; no human fat-loss outcome data [3][4] |
| "Aids weight management" | Body weight is a secondary endpoint in the 2026 MOTS-MET trial; no results available [1][2] |
| "Research-backed for obesity" | MOTS-c is investigational; no established obesity indication [1] |
Readers whose primary goal is weight loss should compare established options. BeSkinny's peptides for weight loss guide covers compounds with stronger clinical outcome data.
What about MOTS-c and insulin sensitivity?
Insulin sensitivity is the primary endpoint being tested in the 2026 MOTS-MET Phase 2 trial, not a settled clinical benefit [1][2].
The MOTS-MET study (NCT07505745), registered February 2026, uses an oral-glucose-tolerance-test-derived insulin sensitivity index as its main outcome measure [1][2]. This positions MOTS-c firmly in hypothesis-testing mode: the compound is investigational, and no peer-reviewed publication has yet established that it reliably improves insulin sensitivity in humans [1][2][3]. Merchant descriptions referencing "glucose uptake" or "improved insulin sensitivity" typically draw from cellular and animal research, not confirmed human results [3][4][5].
A Certificate of Analysis proves identity and purity testing for a specific batch; it does not establish that the product produces any clinical effect on glucose metabolism or insulin function [10][11]. The gap between laboratory characterisation and human outcome data matters here. A buyer cannot verify insulin-sensitivity benefits from a product page, a CoA, or a research-chemical listing.
| Claim encountered | Evidence status | Source type |
|---|---|---|
| "Improves insulin sensitivity" | Unverified in humans | Merchant or research summaries [3][4][5] |
| "Supports glucose metabolism" | Animal and cellular data only | Preclinical literature [3][4] |
| "Clinically tested for insulin resistance" | Phase 2 trial ongoing, no results | Trial registry [1][2] |
South Africans with concerns about blood glucose, prediabetes or metabolic health should discuss these with a qualified healthcare professional. MOTS-c is not an established treatment for insulin-related conditions.
How to check a MOTS-c listing before buying
A practical pre-purchase checklist separates verifiable product and fulfilment facts from unproven benefit claims. Use this ordered process before committing to any MOTS-c order in South Africa.
| Check | What to verify | Why it matters |
|---|---|---|
| Brand and format | Exact product name, SKU, and whether it is a vial, pen or other format | Ensures you are comparing like-for-like; avoids ordering the wrong item |
| Current ZAR price and availability | Listed price in Rand, stock status, and price-validity date | Confirms the offer is current and in budget |
| Batch-specific CoA | Request the Certificate of Analysis for the specific batch before payment | A CoA proves third-party testing for that batch only; generic claims are insufficient [10][11] |
| What the CoA proves | Identity and purity testing by stated method and laboratory | A CoA does not prove clinical efficacy, sterility or human safety [10][11] |
| Delivery boundary | South Africa-only shipping confirmed | Cross-border peptide shipments face customs barriers |
| Cold-chain handling | Stated temperature-controlled storage and dispatch process | Peptide integrity depends on unbroken cold chain from storage to delivery |
| Purchase and support route | Payment methods, order cut-off times, and support channels | Determines whether you can complete and track your order, and get help if needed |
BeSkinny accepts payment by EFT, card or Bitcoin. Orders placed and paid before 12:00 on a business day typically ship same-day; major metros receive next-day delivery, while outlying areas take 2-5 working days. Email support responds within 24 hours on weekdays; WhatsApp support is listed for Monday-Friday 08:00-16:00.
Request the CoA before you pay. A Certificate of Analysis is batch-specific documentation of reported testing, not proof that the product produces fat loss, improved insulin sensitivity or any clinical outcome [10][11]. If the seller cannot provide a CoA linked to the batch you will receive, that is a signal to pause.
Readers comparing MOTS-c with other wellness compounds can review BeSkinny's wellness and recovery peptides. Those evaluating established weight-loss injectables against research-stage options may find BeSkinny's semaglutide buyer's guide more directly relevant.
Buy Body Pharm MOTS-C in South Africa
BeSkinny lists Body Pharm MOTS-C 10 Vial as InStock; see the product page for the current price [12].
| Detail | Value |
|---|---|
| Product | Body Pharm MOTS-C 10 Vial |
| SKU | bpmots10 |
| Price | See the live product page |
| Availability | InStock |
| Purchase URL | https://beskinny.store/shop/body-pharm-mots-c-10 |
We handle products cold-chain from storage through dispatch. Orders placed and paid before 12:00 on a business day typically ship same-day; major metros receive next-day delivery, outlying areas 2-5 working days. We ship within South Africa only.
Request the Certificate of Analysis before you purchase. Every batch is third-party tested for purity and identity, with the CoA available on the product page or by email request.
Shop the full range, every compound, in the strengths that matter.
Sources
- [1] Study Details | NCT07505745 | MOTS-c for Improving Insulin Sensitivity in Adults With Prediabetes and Overweight/Obesity, https://clinicaltrials.gov/study/NCT07505745, 2026
- [2] MOTS-c Enters Human Testing for Prediabetes and Obesity, https://peptidecurrent.com/article/mots-c-moves-into-a-real-human-trial-for-prediabetes-and-obesity, 2026
- [3] MOTS-c Research: What the Evidence Shows, https://purepeptides.com/research/mots-c-research, 2026[unverified]
- [4] Mitochondria-Derived Peptide MOTS-c: From Lab Mice to Early Human Trials, https://supplementscore.org/a/mitochondria-derived-peptide-mots-c-from-lab-mice-to-early-human-trials.html, 2026[unverified]
- [5] MOTS-c Insulin Sensitivity, What Researchers Found in 2026, https://www.realpeptides.co/mots-c-insulin-sensitivity-researchers-found-2026/, 2026[unverified]
- [6] Guideline For Section 21 Access To Unregistered Medicines, https://www.sahpra.org.za/document/guideline-for-section-21-access-to-unregistered-medicines/, 2026
- [7] guidelne for section 21 access to unregistered medicines, https://www.sahpra.org.za/wp-content/uploads/2022/01/SAHPGL-CEM-S21-02_v4-Guideline-for-Section-21-Access-to-Unregistered-Medicines-1.pdf, 2025
- [10] What to Look for in a Certificate of Analysis, https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/certificate-of-analysis, 2024
- [11] Understanding Certificates of Analysis in Pharmaceutical Quality Control, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296571/, 2024
- [12] Body Pharm, MOTS-C 32 Pen, https://www.beskinny.co.za/products/mots-c-32-pen, 2026
- [13] Body Pharm MOTS-C 32 Pen, https://bodypharm.co.za/products/body-pharm-mots-c-32-pen, 2026

